Showing results (691-700 of 713) with videos related to

Sort By:
Pageof 72
Bioorganic & Medicinal Chemistry Letters|January 29, 2013
Development of amino-pyrimidine inhibitors of c-Jun N-terminal kinase (JNK): kinase profiling guided optimization of a 1,2,3-benzotriazole leadWylie S Palmer, Muzaffar Alam, Humberto B Arzeno, et al.
JHEP Reports : Innovation in Hepatology|February 2, 2026
Practice changing RCT design and rationale: Abbreviated MRI plus AFP <i>vs.</i> ultrasound plus AFP for HCC surveillance in cirrhosis (PREMIUM study)George N Ioannou, Tamar H Taddei, Beata M Planeta, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 1, 2006
Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group reportSteven Z Pavletic, Paul Martin, Stephanie J Lee, et al.
American Journal of Ophthalmology|March 9, 2019
Effect of Graft Attachment Status and Intraocular Pressure on Descemet Stripping Automated Endothelial Keratoplasty Outcomes in the Cornea Preservation Time StudyAnthony J Aldave, Mark A Terry, Loretta B Szczotka-Flynn, et al.
Science Immunology|September 8, 2023
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancerGiacomo Oliveira, Ann Marie Egloff, Alexander B Afeyan, et al.
International Journal of Immunogenetics|January 3, 2013
16(th) IHIW: analysis of HLA population data, with updated results for 1996 to 2012 workshop data (AHPD project report)M E Riccio, S Buhler, J M Nunes, et al.
Nature Cancer|May 12, 2026
Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trialElizabeth A R Garfinkle, Renzo Perales-Linares, Ryan C Gimple, et al.
Arxiv|December 19, 2025
ImmunoNX: a robust bioinformatics workflow to support personalized neoantigen vaccine trialsKartik Singhal, Evelyn Schmidt, Susanna Kiwala, et al.
Pageof 72